This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
WisdomTree, Inc. (WT) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for WisdomTree, Inc. (WT) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
WisdomTree, Inc. (WT) Meets Q2 Earnings Estimates
by Zacks Equity Research
WisdomTree, Inc. (WT) delivered earnings and revenue surprises of 0.00% and -1.52%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Oportun Financial Corporation (OPRT) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Oportun Financial (OPRT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Surging Earnings Estimates Signal Upside for WisdomTree, Inc. (WT) Stock
by Zacks Equity Research
WisdomTree, Inc. (WT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Are You Looking for a Top Momentum Pick? Why WisdomTree, Inc. (WT) is a Great Choice
by Zacks Equity Research
Does WisdomTree, Inc. (WT) have what it takes to be a top stock pick for momentum investors? Let's find out.
WisdomTree, Inc. (WT) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
WisdomTree, Inc. (WT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Buy WisdomTree, Inc. (WT) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
WisdomTree, Inc. (WT) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does WisdomTree, Inc. (WT) have what it takes to be a top stock pick for momentum investors? Let's find out.
WisdomTree, Inc. (WT) Moves 6.6% Higher: Will This Strength Last?
by Zacks Equity Research
WisdomTree, Inc. (WT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Strength Seen in Coinbase Global (COIN): Can Its 16.3% Jump Turn into More Strength?
by Zacks Equity Research
Coinbase Global (COIN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
WisdomTree, Inc. (WT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for WisdomTree, Inc. (WT) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
WisdomTree, Inc. (WT) Meets Q1 Earnings Estimates
by Zacks Equity Research
WisdomTree, Inc. (WT) delivered earnings and revenue surprises of 0% and 1.19%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Employers Holdings (EIG) Beats Q1 Earnings Estimates
by Zacks Equity Research
Employers Holdings (EIG) delivered earnings and revenue surprises of 26.09% and 6.55%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Brookfield Asset Management (BAM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Brookfield (BAM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
WisdomTree, Inc. (WT) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
WisdomTree, Inc. (WT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Core Scientific, Inc. (CORZ) Surges 5.3%: Is This an Indication of Further Gains?
by Zacks Equity Research
Core Scientific, Inc. (CORZ) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Compared to Estimates, WisdomTree, Inc. (WT) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for WisdomTree, Inc. (WT) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
WisdomTree, Inc. (WT) Lags Q4 Earnings and Revenue Estimates
by Zacks Equity Research
WisdomTree, Inc. (WT) delivered earnings and revenue surprises of -5.56% and 0.64%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Ideas feature highlights WisdomTree and SoFi Technologies
by Zacks Equity Research
WisdomTree and SoFi Technologies have been highlighted in this Investment Ideas article.
2 Cheap Growth Stocks to Buy Now for Under $20
by Benjamin Rains
Today we dig into two cheap stocks trading for under $20--WisdomTree and SoFi--that investors might want to buy for long-term upside.
All You Need to Know About WisdomTree, Inc. (WT) Rating Upgrade to Buy
by Zacks Equity Research
WisdomTree, Inc. (WT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Regional Management Unveils $30M Buyback Plan & Growth Targets
by Zacks Equity Research
RM targets net receivables to increase 10-12% in 2025.
4 Things You Need to Know Before You Buy Virtu Financial Stock
by Zacks Equity Research
VIRT's financial flexibility enables it to take shareholder-friendly moves.
Discover Financial Unites With Telered, Enhances Payment Acceptance
by Zacks Equity Research
DFS and Telered enter into a strategic alliance to enhance acceptance of their cards and improve the cardholder experience.
Allstate Unveils Flexible Healthcare Solutions With Key Partnerships
by Zacks Equity Research
ALL partners with Thatch, Intuit QuickBooks and Ambetter Health to provide flexible healthcare solutions for customers.